PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

British Patient Capital makes EUR30m commitment to Partech Growth II

British Patient Capital has made a EUR30 million commitment to Partech Growth II, which announced its final close today at EUR650 million.

Partech is one of the most active tech-specialist venture capital firms in the world, and this latest fund is one of the largest growth funds in Europe. It aims to back between 12 and 15 digital scale-ups, investing between EUR20 million and EUR70 milllion in each business across sectors such as enterprise software, consumer, healthcare, financial services, education and other frontier technologies. 
 
Judith Hartley, CEO, British Patient Capital, says: “We are delighted to be partnering with Partech on their latest fund. They have a strong track record in backing innovative tech companies, which includes home-grown success stories such as Made.com and Brandwatch. This EUR30 million commitment aligns with our strategy to support later stage UK businesses, and we look forward to working with Partech to produce the next generation of digital leaders.”
 
Omri Benayoun, General Partner, Partech Growth, says: “We’re humbled and grateful for the support of, and commitment from, our global investors. It allows us to continue to deliver meaningful and strategic assistance to the outstanding community of European tech entrepreneurs who decide to welcome us on their journey.”

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured